Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Patterson

Showing results (1071-1080 of 1,160) with videos related to

Pageof 116
Sort By:
Transfusion Medicine (Oxford, England)|September 6, 2000
Effect of premedication guidelines and leukoreduction on the rate of febrile nonhaemolytic platelet transfusion reactionsB J Patterson, J Freedman, V Blanchette, et al.
Cancer Epidemiology|November 22, 2011
Family history of non-hematologic cancers among Waldenstrom macroglobulinemia patients: a preliminary studyRohit P Ojha, Christina A Hanzis, Zachary R Hunter, et al.
British Journal of Haematology|June 10, 2008
The HMG-CoA inhibitor, simvastatin, triggers in vitro anti-tumour effect and decreases IgM secretion in Waldenstrom macroglobulinaemiaAnne-Sophie Moreau, Xiaoying Jia, Christopher J Patterson, et al.
Hemasphere|July 11, 2020
Response and Survival Outcomes to Ibrutinib Monotherapy for Patients With Waldenström Macroglobulinemia on and off Clinical TrialsJorge J Castillo, Joshua N Gustine, Kirsten Meid, et al.
Neuroradiology|March 21, 2009
Temporal dependence of in vivo USPIO-enhanced MRI signal changes in human carotid atheromatous plaquesT Y Tang, A J Patterson, S R Miller, et al.
Critical Care Medicine|March 25, 2015
Critical Care Delivery: The Importance of Process of Care and ICU Structure to Improved Outcomes: An Update From the American College of Critical Care Medicine Task Force on Models of Critical CareBarry J Weled, Lana A Adzhigirey, Tudy M Hodgman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2009
Primary therapy of Waldenström macroglobulinemia with bortezomib, dexamethasone, and rituximab: WMCTG clinical trial 05-180Steven P Treon, Leukothea Ioakimidis, Jacob D Soumerai, et al.
The Journal of Clinical Investigation|September 5, 2008
Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosisHyung J Chun, Ziad A Ali, Yoko Kojima, et al.
Blood|February 26, 2017
Acquired mutations associated with ibrutinib resistance in Waldenström macroglobulinemiaLian Xu, Nicholas Tsakmaklis, Guang Yang, et al.
Stroke|May 3, 2008
Correlation of carotid atheromatous plaque inflammation using USPIO-enhanced MR imaging with degree of luminal stenosisTjun Y Tang, Simon P S Howarth, Sam R Miller, et al.
Pageof 116

Showing results (1071-1080 of 1,160) with videos related to

Sort By:
Pageof 116
Transfusion Medicine (Oxford, England)|September 6, 2000
Effect of premedication guidelines and leukoreduction on the rate of febrile nonhaemolytic platelet transfusion reactionsB J Patterson, J Freedman, V Blanchette, et al.
Cancer Epidemiology|November 22, 2011
Family history of non-hematologic cancers among Waldenstrom macroglobulinemia patients: a preliminary studyRohit P Ojha, Christina A Hanzis, Zachary R Hunter, et al.
British Journal of Haematology|June 10, 2008
The HMG-CoA inhibitor, simvastatin, triggers in vitro anti-tumour effect and decreases IgM secretion in Waldenstrom macroglobulinaemiaAnne-Sophie Moreau, Xiaoying Jia, Christopher J Patterson, et al.
Hemasphere|July 11, 2020
Response and Survival Outcomes to Ibrutinib Monotherapy for Patients With Waldenström Macroglobulinemia on and off Clinical TrialsJorge J Castillo, Joshua N Gustine, Kirsten Meid, et al.
Neuroradiology|March 21, 2009
Temporal dependence of in vivo USPIO-enhanced MRI signal changes in human carotid atheromatous plaquesT Y Tang, A J Patterson, S R Miller, et al.
Critical Care Medicine|March 25, 2015
Critical Care Delivery: The Importance of Process of Care and ICU Structure to Improved Outcomes: An Update From the American College of Critical Care Medicine Task Force on Models of Critical CareBarry J Weled, Lana A Adzhigirey, Tudy M Hodgman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2009
Primary therapy of Waldenström macroglobulinemia with bortezomib, dexamethasone, and rituximab: WMCTG clinical trial 05-180Steven P Treon, Leukothea Ioakimidis, Jacob D Soumerai, et al.
The Journal of Clinical Investigation|September 5, 2008
Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosisHyung J Chun, Ziad A Ali, Yoko Kojima, et al.
Blood|February 26, 2017
Acquired mutations associated with ibrutinib resistance in Waldenström macroglobulinemiaLian Xu, Nicholas Tsakmaklis, Guang Yang, et al.
Stroke|May 3, 2008
Correlation of carotid atheromatous plaque inflammation using USPIO-enhanced MR imaging with degree of luminal stenosisTjun Y Tang, Simon P S Howarth, Sam R Miller, et al.
Pageof 116